Medical treatment

Abstract

Systems, methods, and other embodiments associated with organism medical treatment are described. In one embodiment, a system can comprise a collection component configured to receive a medical control instruction. The medical control instruction can be based, at least in part, on an organism medical information set for an organism. The system can further comprise a regulation component configured to control administration of a treatment to the organism. The regulation component can control the administration of the treatment to the organism based, at least in part, on the medical control instruction.

What is claimed is: 
     
         1 . A non-transitory computer-readable medium, retained by an orally ingestible housing, retaining an instruction set that when executed by a processor causes a method to be performed, the method comprising:
 causing a medicine, when the orally ingestible housing is within an organism, to be dispensed from a repository at a first rate;   identifying a response, when the orally ingestible housing is within an organism, to the first rate of the medicine; and   causing the medicine, when the orally ingestible housing is within an organism, to be dispensed from the repository at a second rate in reaction, at least in part, to the response, where the first rate and the second rate are different.   
     
     
         2 . The non-transitory computer-readable medium of  claim 1 ,
 where the repository is retained by the orally ingestible housing.   
     
     
         3 . The non-transitory computer-readable medium of  claim 1 , the method comprising:
 determining the response by way of a sensor that is part of the orally ingestible housing.   
     
     
         4 . The non-transitory computer-readable medium of  claim 1 ,
 where the response is identified from a communication received by the orally ingestible housing from outside the orally ingestible housing.   
     
     
         5 . The non-transitory computer-readable medium of  claim 1 ,
 where the first rate is determined from outside the orally ingestible housing and   where the second rate is determined from inside the orally ingestible housing.   
     
     
         6 . The non-transitory computer-readable medium of  claim 1 ,
 where the first rate is determined from inside the orally ingestible housing and   where the second rate is determined from outside the orally ingestible housing.   
     
     
         7 . The non-transitory computer-readable medium of  claim 1 , the method comprising:
 selecting the first rate; and   selecting the second rate based, at least in part, on the response.   
     
     
         8 . The non-transitory computer-readable medium of  claim 1 , the method comprising:
 selecting the second rate based, at least in part, on the response and a medical history of the organism.   
     
     
         9 . The non-transitory computer-readable medium of  claim 1 ,
 where the first rate is about zero.   
     
     
         10 . The non-transitory computer-readable medium of  claim 1 , comprising:
 verifying an identity of the organism,   where causing the medicine to be dispensed from a repository at a first rate occurs after the organism is verified.   
     
     
         11 . An orally ingestible housing, comprising:
 a repository configured to retain a medicine;   a controller configured to cause the medicine to be dispensed from the repository and into an organism;   a regulator configured to set a dispense rate for the medicine into the organism; and   a sensor configured to identify a response by the organism to the medicine,   where the regulator is configured to set the dispense rate to be at a first dispense rate,   where after the medicine, that is dispensed from the repository at the first dispense rate, is in the organism the sensor identifies the response, and   where the regulator is configured to change the dispense rate to a second dispense rate based, at least in part, on the response.   
     
     
         12 . The orally ingestible housing of  claim 11 , comprising:
 a selection component configured to select the second dispense rate based, at least in part, on the response.   
     
     
         13 . The orally ingestible housing of  claim 12 , comprising:
 where the sensor is configured to make a biometric observation that concerns the organism and   where the selection component configured to select the first dispense rate based, at least in part, on the biometric observation.   
     
     
         14 . The orally ingestible housing of  claim 11 , comprising:
 a non-transitory computer-readable medium configured to retain the first dispense rate before the orally ingestible housing enters the gastrointestinal tract of the organism.   
     
     
         15 . The orally ingestible housing of  claim 14 ,
 where the organism is a single person and   where the first dispense rate is a customized selection for the single person.   
     
     
         16 . The orally ingestible housing of  claim 14 ,
 where the organism is a single person and   where the first dispense rate is a generic selection.   
     
     
         17 . The orally ingestible housing of  claim 11 ,
 where the second dispense rate is a rate of about zero.   
     
     
         18 . An orally ingestible housing, comprising:
 a repository configured to retain a medicine;   a sensor configured to identify a biometric abnormality of an organism while the orally ingestible housing is within the organism;   a selection component configured to select a release pattern for the medicine in response to identification of the biometric abnormality; and   a release mechanism configured to cause the medicine to be released in accordance with the release pattern.   
     
     
         19 . The orally ingestible housing of  claim 18 ,
 a transmitter configured to transmit a dataset that details the biometric abnormality to a location outside the organism.   
     
     
         20 . The orally ingestible housing of  claim 18 ,
 where a sensor configured to identify a change in the biometric abnormality of the organism,   where the selection component is configured to modify the release pattern in response to the change in the biometric abnormality, and   where the release mechanism is configured to cause the medicine to be released in accordance with the modified release pattern.